| 000 | 01898 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515050355.0 | ||
| 264 | 0 | _c20070209 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a1347-8613 | ||
| 024 | 7 |
_a10.1254/jphs.fp0060733 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoydan, Guray | |
| 245 | 0 | 0 |
_aShort-term and long-term FK506 treatment alters the vascular reactivity of renal and mesenteric vascular beds. _h[electronic resource] |
| 260 |
_bJournal of pharmacological sciences _cDec 2006 |
||
| 300 |
_a359-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aBosentan |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEndothelin A Receptor Antagonists |
| 650 | 0 | 4 |
_aEndothelin-1 _xmetabolism |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKidney _xblood supply |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aMesentery _xblood supply |
| 650 | 0 | 4 |
_aNitroprusside _xpharmacology |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptor, Endothelin A _xmetabolism |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aTekes, Ender | |
| 700 | 1 | _aTuncer, Meral | |
| 773 | 0 |
_tJournal of pharmacological sciences _gvol. 102 _gno. 4 _gp. 359-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1254/jphs.fp0060733 _zAvailable from publisher's website |
| 999 |
_c16701421 _d16701421 |
||